SFW Capital completed the acquisition of Sannova Analytical.

SFW Capital, a specialized private equity firm, completed the acquisition of Sannova Analytical, a biotechnology company. Financial terms were not disclosed. “We are very excited to partner with the team at Sannova to build on their tremendous success and enhance the value they provide to major pharmaceutical and biotech companies in the U.S. and around the world. The Company is well positioned to take advantage of major industry trends, particularly the increasing tendency of biopharmaceutical companies to outsource critical activities to specialized CROs that can deliver high-quality services with great efficiency. We believe Sannova’s growth can be further accelerated through diversifying the breadth of its service offering, generating greater awareness of its capabilities in the market, and pursuing strategic acquisitions,” Roger Freeman, SFW Co-Founder and Partner.